{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:33:38Z","timestamp":1790836418143,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/ajg.2012.113","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T10:42:12Z","timestamp":1340102532000},"page":"1043-1050","source":"Crossref","is-referenced-by-count":194,"title":["Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy"],"prefix":"10.14309","volume":"107","author":[{"given":"Amit","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barjesh Chander","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"R2-16-20210210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8278(01)00129-5","article-title":"Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.","volume":"35","author":"Amodio","year":"2001","journal-title":"J Hepatol"},{"key":"R3-16-20210210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-0676.2002.01431.x","article-title":"Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy.","volume":"22","author":"Saxena","year":"2002","journal-title":"Liver"},{"key":"R4-16-20210210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.510300316","article-title":"Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis.","volume":"30","author":"Papatheodoridis","year":"1999","journal-title":"Hepatology"},{"key":"R5-16-20210210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510280508","article-title":"Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.","volume":"28","author":"Nolte","year":"1998","journal-title":"Hepatology"},{"key":"R6-16-20210210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-8-46","article-title":"Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study.","volume":"8","author":"Kalaitzakis","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"R7-16-20210210","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1111\/j.1572-0241.2001.04130.x","article-title":"Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.","volume":"96","author":"Romero-Gomez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R8-16-20210210","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with endstage liver disease.","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transpl"},{"key":"R9-16-20210210","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/BF01295920","article-title":"Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.","volume":"38","author":"Camma","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R10-16-20210210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open label randomized controlled trial of lactulose versus placebo.","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"R11-16-20210210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy.","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R12-16-20210210","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2004.11.028","article-title":"Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.","volume":"42","author":"Ortiz","year":"2005","journal-title":"J Hepatol"},{"key":"R13-16-20210210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","volume":"44","author":"DAmico","year":"2006","journal-title":"J Hepatol"},{"key":"R14-16-20210210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1572-0241.2000.02265.x","article-title":"The prognostic significance of subclinical hepatic encephalopathy.","volume":"95","author":"Hartmann","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R15-16-20210210","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"R16-16-20210210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"R17-16-20210210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.","volume":"20","author":"Sharma","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R18-16-20210210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0168-8278(95)80309-2","article-title":"Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.","volume":"23","author":"Loguercio","year":"1995","journal-title":"J Hepatol"},{"key":"R19-16-20210210","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R20-16-20210210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.21586","article-title":"Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.","volume":"45","author":"Romer Gomez","year":"2007","journal-title":"Hepatology"},{"key":"R21-16-20210210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0028-3886.63797","article-title":"Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.","volume":"58","author":"Sharma","year":"2010","journal-title":"Neurol India"},{"key":"R22-16-20210210","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"R23-16-20210210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1440-1746.1995.tb01041.x","article-title":"Figure connection test: a modified number connection test for the objective assessment of mental state in illiterates.","volume":"10","author":"Dhiman","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-16-20210210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis.","volume":"30","author":"Bustamante","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"R26-16-20210210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in vitro and in vivo antibacterial activity a review.","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"R27-16-20210210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00365521.1997.11720717","article-title":"Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection.","volume":"222","author":"Salminen","year":"1997","journal-title":"Scand Gastro"},{"key":"R28-16-20210210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1365-2672.2001.01446.x","article-title":"A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides.","volume":"91","author":"Rycroft","year":"2001","journal-title":"J Applied Microbiol"},{"key":"R29-16-20210210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Christensen KM et al Probiotic yogurt for the treatment of minimal hepatic encephalopathy.","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2012113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201207000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:38:36Z","timestamp":1786541916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201207000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2012.113","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952376.793457842","asserted-by":"object"}]},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}